Cyber Security

Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform

Oct 16, 2026 - 22:30
Biomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT Platform
The launch follows the acquisition of catalog's assets and the appointment of Laurent Guengant as CEO earlier this year.

Read More
Previous Article

Fake Claude, ChatGPT Attacks Surge, Putting Developers at Risk

Next Article

Enterprise AI Enters Risk Management Phase as Security Concerns Rise

Related Posts

Enterprise AI Enters Risk Management Phase as Security Concerns Rise

Enterprise AI Enters Risk Management Phase as Securi...

Oct 16, 2026
UAT-11985 Uses Fake Event Invites to Target Taiwan Research Affiliates With Google AitM Phishing

UAT-11985 Uses Fake Event Invites to Target Taiwan R...

Oct 16, 2026
Attackers Tampered with AOMEI Backupper's Update Servers for Minutes to Deliver a Backdoor

Attackers Tampered with AOMEI Backupper's Update Ser...

Oct 16, 2026
Citizen Lab Traces Zero-Click Candiru Spyware Infections at Al Jazeera to Targeted Online Ads

Citizen Lab Traces Zero-Click Candiru Spyware Infect...

Oct 15, 2026
Why Active Directory weaknesses stay open for years in teams with one or two admins

Why Active Directory weaknesses stay open for years ...

Oct 16, 2026
Fake Arch Linux AUR packages exploit typos to run malware with root privileges

Fake Arch Linux AUR packages exploit typos to run ma...

Oct 16, 2026